Company: NCEL
Filing Date: 2025-03-03
Form Type: F-4/A
Source: 0001213900-25-018981
Chunk: 323

Company: NewcelX Ltd.
Filing Date: 2025-03-03
Form: F-4/A
Chunk 323
---
 cash flows from operations and net loss was $1,236,329 and $1,920,100 for the six months ended June 30, 2024, and June 30, 2023, respectively. During the six months ended June 30, 2024, and June 30, 2023, Kadimastem had negative cash flows from operations of $3,121,258 and $7,312,010, respectively. As of June 30, 2024, Kadimastem’s accumulated deficit was $70,581,692. Kadimastem has funded its operations to date through equity and debt financing and have cash on hand (including short term bank deposits and restricted cash equivalents) of $678,372 as of June 30, 2024. Kadimastem‘s net loss during the fiscals years ending December 31, 2023 and December 31, 2022 was $3.255 (in thousands) and $6.765 (in thousands), respectively. During the fiscal years ending December 31, 2023 and December 31, 2022, Kadimastem had negative cash flows from operations in the amount of $764 thousand and $2.035 (in thousands), respectively. As of December 31, 2023, Kadimastem’s accumulated deficit was $69.345 (in thousands). Between 2021 -2024, Kadimastem raised approximately USD $15.3 million in equity for the issuance of 2,146,899 Kadimastem Ordinary Shares. In the same time period, Kadimastem received grants from the Bird Foundation, the IIA and the Australian Innovation Authority totaling USD $2.4 million. Kadimastem monitors its cash flow projections on a current basis and take active measures to obtain the funding it requires to continue Kadimastem’s operations. However, these cash flow projections are subject to various uncertainties concerning their fulfilment. If Kadimastem is not successful in generating sufficient cash flow or completing additional financing, including debt refinancing which shall release restricted cash, then Kadimastem will need to execute a new cost reduction plan in addition to previous cost reduction plans that were executed so far. Kadimastem’s transition to profitable operations is dependent on generating a level of revenue adequate to support Kadimastem’s cost structure. Kadimastem expects to fund operations using cash on hand, through operational cash flows and raising additional